<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1810482/open_sms">We love to hear from our listeners. Send us a message.</a></p><p>Ken Mills, CEO, President, and Director at REGENXBIO joins Erin Harris for this episode of Cell &amp; Gene: The Podcast to discuss the company&apos;s progress with its Phase I/II Affinity Duchenne trial of RGX-202 for the treatment of Duchenne Muscular Dystrophy. They discuss the future of AAV gene therapy as well as achieving scalability with consistent yield and product purity in gene therapy manufacturing.</p>

Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.